U.S. Markets open in 4 hrs 55 mins
  • S&P Futures

    -6.00 (-0.17%)
  • Dow Futures

    -54.00 (-0.19%)
  • Nasdaq Futures

    -35.75 (-0.31%)
  • Russell 2000 Futures

    -2.60 (-0.16%)
  • Crude Oil

    -0.66 (-1.58%)
  • Gold

    +7.10 (+0.37%)
  • Silver

    +0.18 (+0.70%)

    +0.0028 (+0.2371%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +0.63 (+2.16%)

    +0.0102 (+0.7855%)

    -0.5200 (-0.4930%)

    +1,107.01 (+10.01%)
  • CMC Crypto 200

    +5.58 (+2.34%)
  • FTSE 100

    -69.87 (-1.19%)
  • Nikkei 225

    +72.42 (+0.31%)

Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems

Zacks Equity Research

For Immediate Release

Chicago, IL – May 9, 2019 - Stocks in this week’s article are Exantas Capital Corp. XAN, Lamb Weston Holdings, Inc. LW, Bristol-Myers Squibb Co. BMY, Amedisys, Inc. AMED and Computer Programs and Systems, Inc. CPSI.

5 Stocks with Upgraded Broker Ratings Worth Betting on Now

It’s not easy for an individual investor to pick stocks on his own and gain from it, given several fundamental and technical aspects that need to be considered for spotting potential winners. This is where expert advice comes in handy.

As brokers are in direct communication with companies, they have deeper understanding about them. Hence, following what majority of brokers are saying about a stock can help one understand its potential easily.     

Additionally, they analyze fundamentals of a company and place them against the current economic backdrop to understand out how the stock will fare as an investment. Further, brokers have a deeper insight of the overall industry and economy.

Specifically, brokers analyze a company’s publicly available financial statements, attend conference calls and communicate directly with top management. They even talk to customers to understand what they like or dislike about the products and services offered by the company.

Therefore, there’s comprehensive research behind the rating of a broker on a company’s stock. Naturally, when an analyst upgrades a stock, one can easily rely on it.

Nonetheless, it’s not wise to solely depend on broker upgrades to build an investment portfolio. One must also take into consideration certain other factors to ensure steady returns.

For the rest of this Screen of the Week article please visit Zacks.com at:https://www.zacks.com/stock/news/410864/5-stocks-with-upgraded-broker-ratings-worth-betting-on-now

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Computer Programs and Systems, Inc. (CPSI) : Free Stock Analysis Report
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
Lamb Weston Holdings Inc. (LW) : Free Stock Analysis Report
Amedisys, Inc. (AMED) : Free Stock Analysis Report
Exantas Capital Corp. (XAN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research